Investigational mpox mRNA vaccine more effectively reduces disease severity in primates compared to available vaccines
The most frequently used mpox vaccine provides partial immunity to the disease but isn’t always able to prevent severe symptoms or disease transmission. A new vaccine candidate from Moderna, mRNA-1769, more effectively limits symptoms and […]